Aurora Improves Offerings in Australia with New Range of Premium Dried Flower Products
NASDAQ | TSX:ACB
Canada’s Leading Medical Cannabis Company and MedReleaf Australia Launch Innovative Product to Offer Greater Choice for Patients
EDMONTON, AB, April 30, 2024 /PRNewswire/ – Aurora Cannabis Inc. (NASDAQ: ACB) (TSX:ACB) – the Canadian based leading global medical cannabis company, in conjunction with MedReleaf Australia, is pleased to announce the expansion of its portfolio with the introduction of a new range of premium dried cannabis flower products. Now available for doctors to prescribe to patients in Australia, the new products developed by Aurora and manufactured at its EU-GMP and TGA-GMP certified facility, will be distributed by MedReleaf Australia, a premier distributor of medical cannabis products holding the second position in the Australian market.